Identification of repurposable drugs with beneficial effects on glucose control in type 2 diabetes using machine learning

• Egile Nagusiak: Gideon Koren (Egilea), Galia Nordon (Egilea), Kira Radinsky (Egilea), Varda Shalev (Egilea)
• Formatua: Liburua
• Argitaratua: Wiley, 2019-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Despite effective medications, rates of uncontrolled glucose levels in type 2 diabetes remain high. We aimed to test the utility of machine learning applied to big data in identifying the potential role of concomitant drugs not taken for diabetes which may contribute to lowering blood gluco...